Evaluation of the effects of saphenous venous phlebotomy on pain of sciatica

Not Applicable

• Conditions: umbago with sciatica.; Lumbago with sciatica; M54.4

• Registration Number: IRCT20160627028664N4
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Patients aged 25-65 with pain caused by sciatic nerve compression

Exclusion Criteria

patients with other inflammations in any other part of the body
Diabetic patients
pregnant or Lactating women
coagulopathic patients
Patients with all kinds of physical and mental disabilities
Patients who definitely need surgery based on the neurosurgeon's diagnosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reducing the intensity and extent of patients' pain. Timepoint: Before the intervention, one week and four weeks after the intervention. Method of measurement: Based on the valid and reliable questionnaire (Neuropathic Pain Questionnaire (NPQ) and Neuropathic pain scale (NPS).

Secondary Outcome Measures

Name	Time	Method
Reduction of inflammatory factors and increase of anti-inflammatory factors. Timepoint: before intervention and one week after intervention. Method of measurement: Real-time PCR.